IQVIA Holdings | IQV - Actif À Court Terme





Actif À Court Terme Changement Date
Accenture USD 28.01B 59.36M 2025-12
Agilent USD 4.76B 148M 2026-03
Bruker USD 2.1B 108.9M 2026-03
Cardinal Health USD 38.06B 1.17B 2026-03
Celltrion KRW 470.6B 5.07T 2025-12
Charles River Laboratories USD 1.49B 41.76M 2026-03
Cigna USD 43.03B 4.78B 2026-03
Cognizant Technology Solutions USD 7.84B 716M 2026-03
Computer Programs Systems USD 104.64M 2.07M 2025-12
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
CVS Health USD 74.82B 103M 2026-03
Danaher USD 13.94B 1.18B 2026-03
Dentsply International USD 1.85B 178M 2026-03
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 1.12B 710.47M 2026-03
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Elevance Health USD 67.03B 4.03B 2026-03
Humana USD 38.08B 5.35B 2026-03
IBM USD 31.91B 5.03B 2026-03
Illumina USD 2.74B 551M 2026-03
Infosys INR 904.58B 153.09B 2025-12
Kangmei Pharma CNY 6.8B 225.83M 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Laboratory Of America USD 4.56B 538.3M 2026-03
Malin Corporation EUR 62.6M 26.7M 2024-12
McKesson USD 57.21B 2.49B 2026-03
Mettler Toledo International USD 1.33B 30.76M 2026-03
Organigram Holdings CAD 256.54M 28.35M 2025-12
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pharma Mar EUR 273.45M 9.96M 2026-03
Publicis EUR 23.07B 3.72B 2025-12
Qiagen NV USD 2B 535.87M 2025-12
Quest Diagnostics USD 2.57B 188M 2026-03
Revvity USD 2.13B 111.43M 2026-03
Sartorius EUR 1.92B 157.2M 2026-03
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Tilray USD 729.32M 28.18M 2025-09
UnitedHealth USD 91.13B 545M 2026-03
Veeva Systems USD 8.06B 65.63M 2026-03
Veradigm USD 679.65M 131.12M 2022-12
Waters USD 3.72B 1.73B 2026-03
Zealand Pharma A/S 15.67B 950.94M 2025-12
Zz Pientze Pharmaceu CNY 11.43B 728.95M 2026-03